FindTrial
Sign In

Radiotherapy for brain tumors

Disease outcomes and treatment toxicities of hypofractionated radiotherapy for newly diagnosed high grade gliomas- A prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032867
Enrollment
32
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G938- Other specified disorders of brain

Interventions

None listed

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed high grade glioma post resection Performance Score 2/5

Exclusion criteria

Exclusion criteria: Recurrent disease Poor Performance score

Design outcomes

Primary

MeasureTime frame
Progression Free SurvivalTimepoint: 4 months,8 months and 12 months—

Secondary

MeasureTime frame
Overall Survival Adverse effects of treatmentTimepoint: 6 and 12 months—

Countries

India

Contacts

Public ContactDr Sheel Mohanty

KMC Manipal

tk.sharan@manipal.edu9448625116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026